Phenotype of recombinant Trypanosoma cruzi which overexpress elongation factor 1-γ: Possible involvement of EF-1γ GST-like domain in the resistance to clomipramine

Gene

Volumn 198, Issue 2 JAN, 1997, Pages 259-267

  Billaut Mulot, Odile ^a   Fernandez Gomez, Rodolfo ^a   Ouaissi, Ali ^b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b INSERM   (France)

Author keywords

Drug resistance; Elongation factor 1 ; Transfection; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; CLOMIPRAMINE; ELONGATION FACTOR 1; GLUTATHIONE TRANSFERASE; NIFURTIMOX;

ARTICLE; CANCER GROWTH; CELL GROWTH; CONJUGATION; CONTROLLED STUDY; DRUG DETOXIFICATION; DRUG RESISTANCE; DRUG SENSITIVITY; GLUTATHIONE METABOLISM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SHUTTLE VECTOR; TRYPANOSOMA CRUZI;

ANIMALS; CLOMIPRAMINE; DNA, COMPLEMENTARY; DRUG RESISTANCE; GLUTATHIONE TRANSFERASE; NIFURTIMOX; NITROIMIDAZOLES; PEPTIDE ELONGATION FACTOR 1; PEPTIDE ELONGATION FACTORS; PHENOTYPE; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EUKARYOTA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0030724906     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0378-1119(97)00323-5     Document Type: Article

References (31)

1. Bellé, R., Derancourt, J., Poulhe, R., Capony, J.P., Ozon, R., Mulner-Lorillon, O., A purified complex from Xenopus oocytes contains a p47 protein, an in vitro substrate of MPF, and a p30 protein respectively homologous to elongation factors EF-1γ and EF-1β. 1989. FEBS Lett. 255, 101-104.
2. Benson, T.J., Mckie, J.H., Garforth, J., Borges, A., Fairlamb, A.H., Douglas, K.T., 1992. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures. Biochem. J. 286, 9-11.
3. Billaut-Mulot, O., Pommier, V., Schôneck, R., Plumas-Marty, B., Taibi, A., Loyens, M., Capron, A., Ouaissi, A., 1993. Nucluotide sequence of a Trypanosoma cruzi cDNA encoding a protein homologous to mammalian EF-1γ. Nucleic Acids Res. 21, 3901-3901.
4. Billaut-Mulot, O., Schöneck, R., Fernandez-Gomez, R., Taibi, A., Capron, A., Ouaissi, A., 1994. Molecular and immunological characterization of a Trypanosoma cruzi protein homologous to mammalian elongation factor 1 gamma. Biol. Cell. 82, 39-44.
5. Billaut-Mulot, P., Fernandez-Gomez, R., Ouaissi, A., 1996. Trypanosoma cruzi elongation factor 1-α: nuclear localization in parasites undergoing apoptosis. Gene 174, 19-26.
6. Boucher, D.M., Iannaccone, P.M., 1995. Overexpression of human glutathione S-transferase π protects NIH 3T3 cells against (+) anti BPDE cytotoxicity but not tumor formation. Pathobiology 63, 197-203.
7. Brener, Z., 1980. Immunity to Trypanosoma cruzi. Adv. Parasitol. 18, 247-292.
8. Docampo, R., Moreno, S.N.J., 1984. Free radical metabolites in the mode of action of chemotherapeutic agents and phagocytic cells on Trypanosoma cruzi. Rev. Inf. Dis. 6, 223-238.
9. Doyle, P.S., Weinbach, E.C., 1989. The activity of tricyclic antidepressant drugs against Trypanosoma cruzi. Exp. Parasitol. 68, 230-234.
10. Fairlamb, A.H., Blackburn, P., Ulrich, P., Chait, B.T., Cerami, A., 1985. Trypanothione: a novel bis (glutathionyl) spermidine cofactor for glutathione reductase in trypanosomatids. Science 227, 1485-1487.
11. Janssen, G.M.C., Möller, W., 1988a. Kinetic studies on the role of elongation factors 1βand 1γ in protein synthesis. J. Biol. Chem. 263, 1773-1778.
12. Janssen, G.M.C., M̈ller, W., 1988b. Elongation factor 1βγ from Artemia. Purification and properties of its subunits. Eur. J. Biochem. 171, 119-129.
13. Kelly, J.M., Ward, H.M., Miles, M.A., Kendall, G., 1992. A shuttle vector which facilitates the expression of transfected genes in Trypanosoma cruzi and Leishmania. Nucleic Acids Res. 20, 3963-3969.
14. Koonin, E.V., Mushegian, A.R., Tatusov, R.L., Altschul, S.F., Bryant, S.H., Bork, P., Valencia, A., 1994. Eukaryotic translation elongation factor 1γ contains a glutathione transferase domain: study of a diverse ancient protein superfamily using motif search and structural modeling. Prot. Sci. 3, 2045-2054.
15. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
16. Lew, Y., Jones, D.V., Mars, W.M., Evans, D., Byrd, D., Frazier, M.L., 1992. Expression of elongation factor 1 gamma-related sequence in human pancreatic cancer. Pancreas 7, 144-152.
17. Mannervik, B., Alin, P., Guthenberg, C., Jensson, H., Tahir, M.K., Warhholm, M., Jornvall, H., 1985. Identification of three classes of cytosolic glutathione transferases common to several mammalian species: correlation between structural data and enzymatic properties. Proc. Natl. Acad. Sci. USA 82, 7202-7210.
18. Medina-Acosta, E., Cross, G.A.M., 1993. Rapid isolation of DNA from trypanosomatid protozoa using a simple 'mini-prep' procedure. Mol. Biochem. Parasitol. 59, 327-330.
19. Merrick, W.C., 1992. Mechanism and regulation of eukaryotic protein synthesis. Microbiol. Rev. 56, 291-315.
20. Mimori, K., Mori, M., Inoue, H., Ueo, H., Mafume, K., Akiyoshi, T., Sugimachi, K., 1996. Elongation factor 1γ mRNA expression in oesophageal carcinoma. Gut 38, 66-70.
21. Morello, A., 1988. The biochemistry of the mode of action of the drugs and the detoxification mechanism in Trypanosoma cruzi. Comp. Biochem. Physiol. 90, 1-12.
22. Moncayo, A., 1993. In: Progress: 1991-1992. Eleventh report special programme for research and training in tropical diseases, 67.
23. Morgan, A.S., Ciaccio, P.J., Kenneth, D.T., Kauvar, L.M., 1996. Isozyme specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemother. Pharmacol. 37, 363-370.
24. Ouaissi, M.A., Dubremez, J.F., Kusnier, J.P., Cornette, J., Loyens, M., Taibi, A., Marty, B., Velge, P., Rizvi, F., Capron, A., 1990. Trypanosoma cruzi: differential expression and distribution of 85 kDa polypeptide epitope by in vitro developmental stages. Exp. Parasitol. 71, 207-217.
25. Ouaissi, A., Aguirre, T., Plumas-Marty, B., Piras, M., Schöneck, R., Gras-Masse, H., Taibi, A., Loyens, M., Tartar, A., Capron, A., Piras, R., 1992. Cloning and sequencing of a 24 kDa Trypanosoma cruzi specific antigen released in association with membrane vesicles and defined by a monoclonal antibody. Biol. Cell. 75, 11-17.
26. Plumas-Marty, B., Verwaerde, C., Loyens, M., Velge, P., Taibi, A., Cesbron, M.F., Capron, A., Ouaissi, A., 1992. Trypanosoma cruzi glutathione-binding proteins: immunogenicity during human experimental Chagas' disease. Parasitology 104, 87-98.
27. Plumas-Marty, B., Schöneck, R., Billaut-Mulot, O., Taibi, A., Capron, A., Ouaissi, A., 1994. Molecular cloning of a Trypanosoma cruzi cDNA encoding a protein homologous with mammalian elongation factor 1β. Parasitol. Res. 80, 62-66.
28. Sambrook, J., Frisch, E.F., Maniatis, T., 1989. Molecular Cloning. A Laboratory Manual, 2nd edn. Laboratory Press, Cold Spring Harbor Press, Cold Spring Harbor, NY.
29. Sanders, J., Maassen, J.A., Möller, W., 1992. Elongation factor-1 messenger-RNA levels in cultured cells are high compared to tissue and are not drastically affected further by oncogenic transformation. Nucleic Acids Res. 20, 5907-5910.
30. Takle, G.B., Snary, D., 1993. South American Trypanosomiasis (Chagas' disease). In: Warren, K.S. (Ed.), Immunology and Molecular Biology of Parasitic Infections, 3rd ed. Blackwell Scientific, pp. 213-236.
31. Tibayrenc, M., Ayala, F.J., 1988. Isoenzyme variability in Trypanosoma cruzi, the causative agent of Chagas' disease, genetical, taxonomical, and epidemiological significance. Evolution 42, 277-279.